How to Register

Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL Volume 81-82 Page 1-7 published_at 2016

アクセス数 : 980 件

ダウンロード数 : 0 件

今月のアクセス数 : 53 件

今月のダウンロード数 : 0 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53573

Title	Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Creator	Kinoshita Yoshikazu Sakurai Yuuichi Shiino Madoka Kudou Kentaro Nishimura Akira Miyagi Takuya Iwakiri Katsuhiko Umegaki Eiji Ashida Kiyoshi
Source Title	CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
Volume	81-82
Start Page	1
End Page	7
Journal Identifire	ISSN 0011-393X EISSN 1879-0313
Subjects	gastroesophageal reflux; heartburn; NERD; nonerosive gastroesophageal reflux disease; potassium-competitive acid blockers; vonoprazan ( Other)
Language	eng
Resource Type	journal article
Publisher	ELSEVIER SCIENCE INC
Date of Issued	2016
Access Rights	metadata only access
Relation	[DOI] 10.1016/j.curtheres.2016.12.001 [PMID] 28119763
Remark	This work was supported by Takeda Pharmaceutical Company Limited, manufacturer / licensee of vonoprazan. Medical writing assistance was provided by Elise Magatova, PhD, and Tania Dickson, PhD, of ProScribe - Envision Pharma Group, and was funded by Takeda Pharmaceutical Company Limited. ProScribe's services complied with international guidelines for Good Publication Practice (GPP3).